Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C
Clinical trial NCT03893071 · UNKNOWN
Trial details
- NCT number
- NCT03893071
- Sponsor
- Cyclo Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2022-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.